Science Resources RSS Feeds
|
 |
 |
 |
Bisphosphonates Current Events | Bisphosphonates News
|
|
|
Sort By:
Page Views | Date |
Bisphosphonate drugs reduce the risk of broken bones in breast cancer patients
Bisphosphonate drugs reduce the risk of bone complications when used in patients whose cancer has spread to the bone, according to a new study in the BMJ. view more (2003-08-29)
Bisphosphonate treatment is associated with jaw bone problems
Patients treated with intravenous bisphosphonates are at an increased risk of jaw or facial bone deterioration or infection. view more (2007-06-27)
Oral bisphosphonate risk slight, but dental patients should be aware, ADA says
People taking oral bisphosphonates, a type of drug used to treat osteoporosis, osteopenia and Paget's disease of bone, should be aware of potential risks when undergoing certain dental procedures. view more (2006-08-07)
Drugs used to fight cancer-related bone problems boost odds of jaw- or face-bone disease
Treatment with intravenous bisphosphonates - drugs used to reduce harm done to bones by cancer or cancer therapy - increases the risk of jaw or facial bone disease or infection, a large-scale comparative study by researchers at the University of Texas Medical Branch at Galveston (UTMB) has found. view more (2007-06-27)
Oral osteoporosis meds appear to reduce the risk of jaw degradation
Athanasios Zavras began receiving messages from distraught patients in 2005 after case reports linked oral osteoporosis meds to bone death in the jaw. view more (2008-01-03)
Skeletal microdamage stable after first year
Skeletal microdamage resulting from bisphosphonate treatment may be maximal during the first year of treatment, and not continue to accumulate with longer periods of treatment, according to new research being presented today at the 28th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR). view more (2006-09-21)
Popular osteoporosis drugs triple risk of bone necrosis
A University of British Columbia and Vancouver Coastal Health Research Institute study has found that a popular class of osteoporosis drugs nearly triples the risk of developing bone necrosis, a condition that can lead to disfigurement and incapacitating pain. view more (2008-01-16)
Link between widely used osteoporosis drugs and heart problems probed
New research at Wake Forest University School of Medicine evaluated the link between a common class of drugs used to prevent bone fractures in osteoporosis patients and the development of irregular heartbeat. view more (2009-04-07)
X-rays help predict permanent bone damage from bisphosphonates
Breast cancer patients, individuals at risk for osteoporosis and those undergoing certain types of bone cancer therapies often take drugs containing bisphosphonates. view more (2009-05-08)
Drug used for advanced cancer could cause exposed bone in jaw
A type of drug used to strengthen bones when cancer has spread there may be linked to a side effect that involves deterioration of the jaw bone, according to two new reviews of cancer literature. view more (2006-10-03)
Mayo Clinic: New recommendations for use of bisphosphonates in treatment of multiple myeloma
Mayo Clinic's multiple myeloma (MM) research team has jointly issued a consensus statement regarding the use of bisphosphonates to prevent or treat bone disease in MM. view more (2006-08-11)
Treating osteoporosis calls for physician, dentist collaboration: ADA Journal
Physicians and dentists should collaborate to improve early detection and treatment of patients who have or may develop osteoporosis, say researchers in the cover story of the May issue of The Journal of the American Dental Association. view more (2008-05-16)
Down in the mouth?
A woman's mouth has a lot to say, even when it's not talking. Things that alter the female body, such as prescription medications to help prevent diseases such as osteoporosis or depression, diabetes, or a vitamin deficiency, can affect a woman's oral health. view more (2007-06-26)
New way to target and kill antibiotic-resistant bacteria found
Putting bacteria on birth control could stop the spread of drug-resistant microbes, and researchers at the University of North Carolina at Chapel Hill have found a way to do just that. view more (2007-07-10)
New drug agent knocks out multiple enzymes in cancer pathway
A team of 24 researchers from the U.S., Europe, Taiwan and Japan and led by University of Illinois scientists has engineered a new anti-cancer agent that is about 200 times more active in killing tumor cells than similar drugs used in recent clinical trials. view more (2009-03-26)
Space-related radiation research could help reduce fractures in cancer survivors
A research project looking for ways to reduce bone loss in astronauts may yield methods of improving the bone health of cancer patients undergoing radiation treatment. view more (2009-09-16)
Denosumab increases bone density, cuts fracture risk in prostate cancer survivors
Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer. view more (2009-08-11)
Women may be able to 'take break' from osteoporosis drug without losing benefit
Most postmenopausal women who took the osteoporosis drug alendronate for 5 years and then stopped did not have an increased risk for nonvertebral fractures in the next 5 years, suggesting the medication has a lasting effect, according to a study in the December 27 issue of JAMA. view more (2006-12-27)
Once-yearly treatment significantly reduces bone fractures in women with postmenopausal osteoporosis
Data to be published in this week's issue of The New England Journal of Medicine show that a once-yearly treatment significantly reduced the incidence of all types of osteoporotic bone fractures over three years in women with postmenopausal osteoporosis. view more (2007-05-03)
POOR PREDICTION OF OSTEOPOROSIS AFTER HEART OR LIVER TRANSPLANTATION (pp 325, 342)
The lack of identification of clear risk factors for osteoporotic fractures after organ transplantation reported in this week’s issue of THE LANCET suggests that future post-transplantation treatment should aim to prevent osteoporosis. Osteoporosis and related fractures are a major complication after organ transplantation. Gudrun... view more... (2001-01-31)
|
|
|
|
Sort By:
Page Views | Date |
|
|
